Association of Pre-Transplant Lymphopenia with Post-Liver Transplantation Complications
DOI:
https://doi.org/10.21276/apalm.3527Keywords:
Absolute lymphocyte count, Post liver transplant, Model for end stage liver disease, Cytomegalovirus, Live donor liver transplantAbstract
Background: Liver transplant is a definitive cure for end-stage liver disease, but organ shortages demand better patient prioritization methods. Absolute lymphocyte count [ALC] may indicate the outcomes, though its role in early post-transplant results needs further study.
Methods: This retrospective study analyzed medical records of 7-month to 75-year-old patients undergoing primary liver transplants at ILBS, New Delhi, from September 2010 to April 2023, excluding cases lacking ALC results or meeting other criteria.
Results: This study included 581 patients, median age 45 years, predominantly male [476], with ethanol-induced chronic liver disease common. MELD 22.7, ascites [378]. encephalopathy [211], and CMV positivity [124]. The low ALC group had higher MELD scores, while ascites [73.7%), encephalopathy [38.7%], and CMV positivity [26.8%] were more common in the adequate ALC group. Within 30 days post-LT. bacterial infections were more common in the adequate ALC group [45% vs. 13%]. while rejection was more frequent in the low ALC group [19.6% vs. 7%]. Sepsis from gram-negative bacteria was a major cause of death. Persistent post-transplant lymphopenia [ALC<500/μL at LT and POD30] was associated with 40 of 62 patients experiencing mortality. Culture-positive infections (84.3% vs. 16.6%) and CMV (34.5% vs. 16.6%) were higher in the complication group.
Conclusion: No effect of low ALC on mortality.
References
1. Klein KB, Stafinski TD, Menon D. Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature. PLoS One. 2013;8(12), e80661.
2. Ma T. Li QS, Wang Y, et al. Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation. World J Gastroenterol. 2019;25(15):1879-1889.
3. Kanda M, Mizuno A, Tanaka C, et al. Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Medicine. 2016;95(24), e3781.
4. Nagai S, Yoshida A, Kohno K et al. Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantation. Hepatology. 2014 59(1):35-45.
5. Ray-Coquard I, Cropet C, Van Glabbeke M, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009;69(13):5383-5391.
6. Fogar P, Sperti C, Basso D, et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas. 2006;32(1):22-28.
7. Clark EJ, Connor S, Taylor MA, Madhavan KK, Garden OJ, Parks RW. Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford). 2007:9(6):456-460.
8. Kanda M, Fujii T. Kodera Y, Nagai S, Takeda S, Nakao A. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98(2):268-274.
9. Fernández-Ruiz M, López-Medrano F, Romo EM, et al. Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation. Liver Transpl. 2009;15(10):1209-1216.
10. Kitajima T, Moonka D, Yeddula S, et al. Outcomes in living donor compared with deceased donor primary liver transplantation in lower acuity patients with model for end-stage liver disease scores 130. Liver Transpl. 2021 27(7):971-983.
11. Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014:61(6):1385-1396.
12. Leithead JA, Rajoriya N, Gunson BK, Ferguson JW. Neutrophil-to-lymphocyte ratio predicts mortality in patients listed for liver transplantation. Liver Int. 2015;35(2): 502-509.
13. Ly M. Crawford M, Verran D. Biliary complications in donation after circulatory death liver transplantation: the Australian National Liver Transplantation Unit's experience. ANZ J Surg. 2021;91(3):445-450.
14. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004:240(2):205-213.
15. Kamo N, Kaido T, Miyachi Y, et al. Preoperative abnormal body composition is closely related to bacteremia after living donor liver transplantation. Nutrition. 2020; 77, 110798.
16. Nagai S, Mangus RS, Anderson E, et al. Cytomegalovirus infection after intestinal/multivisceral transplantation: a single-center experience with 210 cases. Transplantation. 2016;100(2):451-460.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Monica Puri, Chhagan Bihari
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
